Eric C. Holland

38.5k citations

230 papers · 25.7k indexed · 15 hit papers · h-index 77

Impact in

Genetics top 0.01%
- Glioma Diagnosis and Treatment
Developmental Neuroscience top 0.1%
- Neurogenesis and neuroplasticity mechanisms

Papers in

Genetics 105
- Glioma Diagnosis and Treatment 105
Developmental Neuroscience 14

Co-authors: Jason T. Huse Dolores Hambardzumyan Cameron Brennan Nikki Charles Chengkai Dai Raymond Sawaya Gregory N. Fuller Joseph Celestino
Journals: Cancer Research (14 papers)Neuro-Oncology (12 papers)Oncogene (11 papers)PLoS ONE (11 papers)Neoplasia (10 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Eric C. Holland

227 papers receiving 25.3k citations

Hit Papers

15 papers align trajectories log scale

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas 2020 · 310 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Acta Neuropathologica
2019 Nature Communications
2018 Acta Neuropathologica
2016 Science
2014 Cell stem cell
2013 Nature Medicine
2011 Glia
2011 Glia
2010 Nature reviews. Cancer
2009 Cell stem cell
2001 Journal of neurosurgery
2001 Genes & Development
2000 Proceedings of the National Academy of Sciences
2000 Proceedings of the National Academy of Sciences
2000 Nature Genetics

Peers

Countries citing papers authored by Eric C. Holland

Since Specialization

Citations

This map shows the geographic impact of Eric C. Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric C. Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric C. Holland more than expected).

Fields of papers citing papers by Eric C. Holland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric C. Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric C. Holland. The network helps show where Eric C. Holland may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric C. Holland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric C. Holland Line = papers co-authored together Eric C. Holland links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3/4 Neuro-Oncology Advances ·Abigail G Parrish, Sonali Arora, H. Nayanga Thirimanne, Dmytro Rudoy, Sebastian Schmid, Philipp Sievers, Felix Sahm, Eric C. Holland, Frank Szulzewsky	2024	2
2	Phase separation of YAP-MAML2 differentially regulates the transcriptome Proceedings of the National Academy of Sciences ·Chan-I Chung, Junjiao Yang, Xiaoyu Yang, Hongjiang Liu, Zhimin Ma, Frank Szulzewsky, Eric C. Holland, Yin Shen, Xiaokun Shu	2024	13
3	Oncogenic role of a developmentally regulated NTRK2 splice variant Science Advances ·Siobhan S. Pattwell, Sonali Arora, Nicholas Nuechterlein, Michael Zager, Keith R. Loeb, Patrick J. Cimino, Nikolas C. Holland, Noemi Reche-Ley, Hamid Bolouri, Damian A. Almiron Bonnin, Frank Szulzewsky, Vaishnavi V. Phadnis, Tatsuya Ozawa, Michael J. Wagner, Michael C. Haffner, Junyue Cao, Jay Shendure, Eric C. Holland	2022	3
4	Incorporating genomic signatures into surgical and medical decision-making for elderly glioblastoma patients Neurosurgical FOCUS ·Chibawanye Ene, Patrick J. Cimino, Howard A. Fine, Eric C. Holland	2020	4
5	Variability in estimated gene expression among commonly used RNA-seq pipelines Scientific Reports ·Sonali Arora, Siobhan S. Pattwell, Eric C. Holland, Hamid Bolouri	2020	36
6	Anti–PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma Neuro-Oncology ·Chibawanye Ene, Shannon Kreuser, M. Katherine Jung, Huajia Zhang, Sonali Arora, Kara White Moyes, Frank Szulzewsky, Jason Barber, Patrick J. Cimino, Hans‐Georg Wirsching, Anoop P. Patel, Paul Kong, Timothy Woodiwiss, Sharon Durfy, A. McGarry Houghton, Robert H. Pierce, Ian F. Parney, Courtney A. Crane, Eric C. Holland	2019	42
7	Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9 Neuro-Oncology ·Hans‐Georg Wirsching, Sonali Arora, Huajia Zhang, Frank Szulzewsky, Patrick J. Cimino, Christophe Quéva, A. McGarry Houghton, Joseph C. Glorioso, Michael Weller, Eric C. Holland	2019	8
8	Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations Molecular Cancer Research ·Anthony Wang, David Jones, Isaac Joshua Abecassis, Bonnie Cole, Sarah Leary, Christina M. Lockwood, Lukas Chávez, David Capper, Andrey Korshunov, Aria Fallah, Shelly Wang, Chibawanye Ene, James M. Olson, J. Russell Geyer, Eric C. Holland, Amy Lee, Richard G. Ellenbogen, Jeffrey G. Ojemann	2018	37
9	Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity iScience ·Tatjana Wallmann, Xing‐Mei Zhang, Majken Wallerius, Sara Bolin, Anne‐Laure Joly, Caroline Sobocki, Lina Leiss, Yiwen Jiang, Jonas Bergh, Eric C. Holland, Per Øyvind Enger, John Andersson, Fredrik J. Swartling, Hrvoje Miletić, Lene Uhrbom, Robert A. Harris, Charlotte Rolny	2018	38
10	A High-Content Assay Strategy for the Identification and Profiling of ABCG2 Modulators in Live Cells Assay and Drug Development Technologies ·Christophe Antczak, Boyoung Wee, Constantin Radu, Bhavneet Bhinder, Eric C. Holland, Hakim Djaballah	2013	8
11	Candidate Pathways for Promoting Differentiation or Quiescence of Oligodendrocyte Progenitor-like Cells in Glioma Cancer Research ·Joseph D. Dougherty, Elena I. Fomchenko, Afua A. Akuffo, Eric F. Schmidt, Karim Y. Helmy, Elena Bazzoli, Cameron Brennan, Eric C. Holland, Ana Milosevic	2012	54
12	53BP1 Is a Haploinsufficient Tumor Suppressor and Protects Cells from Radiation Response in Glioma Cancer Research ·Massimo Squatrito, Fabio Vanoli, Nikolaus Schultz, Maria Jasin, Eric C. Holland	2012	32
13	Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment PLoS ONE ·Amanda Katz, Nduka Amankulor, Kenneth L. Pitter, Karim Y. Helmy, Massimo Squatrito, Eric C. Holland	2012	68
14	Cyclin D1 and Cdk4 Mediate Development of Neurologically Destructive Oligodendroglioma Cancer Research ·Daniel Ciznadija, Yuhui Liu, Stephanie M. Pyonteck, Eric C. Holland, Andrew Koff	2011	33
15	Recruited Cells Can Become Transformed and Overtake PDGF-Induced Murine Gliomas In Vivo during Tumor Progression PLoS ONE ·Elena I. Fomchenko, Joseph D. Dougherty, Karim Y. Helmy, Amanda Katz, Alexander Pietras, Cameron Brennan, Jason T. Huse, Ana Milosevic, Eric C. Holland	2011	59
16	Preclinical Evaluation of Radiation and Perifosine in a Genetically and Histologically Accurate Model of Brainstem Glioma Cancer Research ·Oren J. Becher, Dolores Hambardzumyan, Talia R. Walker, Karim Y. Helmy, Javad Nazarian, Steffen Albrecht, Rebecca L. Hiner, Sarah Gall, Jason T. Huse, Nada Jabado, Tobey J. MacDonald, Eric C. Holland	2010	130
17	Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and p27Kip1 Localization Cancer Research ·Bobby Bhatia, Paul A. Northcott, Dolores Hambardzumyan, Baskaran Govindarajan, Daniel J. Brat, Jack L. Arbiser, Eric C. Holland, Michael D. Taylor, Anna Marie Kenney	2009	34
18	Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor–Induced Gliomas Cancer Research ·Oren J. Becher, Dolores Hambardzumyan, Elena I. Fomchenko, Hiroyuki Momota, Lori Mainwaring, Anne-Marie Bleau, Amanda Katz, Mark Edgar, Anna Marie Kenney, Carlos Cordon‐Cardo, Ron G. Blasberg, Eric C. Holland	2008	151
19	Huntingtin Interacting Protein 1 Is a Novel Brain Tumor Marker that Associates with Epidermal Growth Factor Receptor Cancer Research ·Sarah V. Bradley, Eric C. Holland, Grace Y. Liu, Dafydd G. Thomas, Teresa S. Hyun, Theodora S. Ross	2007	47
20	Perifosine Inhibits Multiple Signaling Pathways in Glial Progenitors and Cooperates With Temozolomide to Arrest Cell Proliferation in Gliomas In vivo Cancer Research ·Hiroyuki Momota, Edward Nerio, Eric C. Holland	2005	145

About Eric C. Holland

Eric C. Holland is a scholar working on Genetics, Developmental Neuroscience, Cancer Research, Oncology and Molecular Biology, having authored 230 papers that have together received 25.7k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (105 papers), Cancer Cells and Metastasis (23 papers), MicroRNA in disease regulation (22 papers), RNA Research and Splicing (21 papers), Hedgehog Signaling Pathway Studies (20 papers), Immune cells in cancer (19 papers), Cancer-related Molecular Pathways (16 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Genetics (10.1k citations), Developmental Neuroscience (1.7k citations), Cancer Research (5.8k citations), Oncology (6.3k citations) and Immunology (4.7k citations). Eric C. Holland has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Jason T. Huse, Dolores Hambardzumyan, Cameron Brennan, Nikki Charles, Chengkai Dai, Raymond Sawaya, Gregory N. Fuller, Joseph Celestino, Elena I. Fomchenko and Sandy Feng. Their work appears in journals such as Cancer Research, Neuro-Oncology, Oncogene, PLoS ONE and Neoplasia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact